Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Publication Year: 2012

DOI:
10.1007/s00535-012-0591-2

PMCID:
PMC3501170

PMID:
22539101

Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest A.C. was supported by a grant from MRC Technology (MRCT). J.L.B. and S.H.W. were supported by a grant from Centocor R&D, Inc. A.N.J.M. and J.L.B. declare a financial interest in the anti-IL-25 antibody."

Evidence found in paper:

"Conflict of interestA.C. was supported by a grant from MRC Technology (MRCT). J.L.B. and S.H.W. were supported by a grant from Centocor R&D, Inc. A.N.J.M. and J.L.B. declare a financial interest in the anti-IL-25 antibody."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025